Deutsche Bank Ag\ Oncocyte Corp Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.2 - $0.49 $6,756 - $16,552	-33,780 Reduced 49.92%	33,890 $11,000
Q2 2022 Aug 11, 2022	BUY	$0.86 - $1.53 $14,168 - $25,206	16,475 Added 32.18%	67,670 $61,000
Q1 2022 May 13, 2022	BUY	$1.15 - $2.25 $14,318 - $28,014	12,451 Added 32.14%	51,195 $77,000
Q4 2021 Feb 11, 2022	SELL	$2.04 - $3.59 $24,610 - $43,309	-12,064 Reduced 23.74%	38,744 $84,000
Q3 2021 Nov 04, 2021	BUY	$3.53 - $5.89 $18,038 - $30,097	5,110 Added 11.18%	50,808 $181,000
Q2 2021 Aug 11, 2021	SELL	$3.77 - $6.0 $5,651 - $8,994	-1,499 Reduced 3.18%	45,698 $263,000
Q1 2021 May 13, 2021	BUY	$2.39 - $6.5 $1,675 - $4,556	701 Added 1.51%	47,197 $244,000
Q4 2020 Feb 16, 2021	BUY	$1.38 - $2.63 $17,483 - $33,319	12,669 Added 37.45%	46,496 $111,000
Q3 2020 Nov 12, 2020	BUY	$1.2 - $1.89 $13,944 - $21,961	11,620 Added 52.33%	33,827 $47,000
Q2 2020 Aug 13, 2020	BUY	$1.91 - $3.45 $28,926 - $52,250	15,145 Added 214.46%	22,207 $42,000
Q1 2020 May 14, 2020	SELL	$1.76 - $3.02 $760 - $1,304	-432 Reduced 5.76%	7,062 $17,000
Q4 2019 Feb 14, 2020	BUY	$1.51 - $2.27 $2,245 - $3,375	1,487 Added 24.75%	7,494 $16,000
Q3 2019 Nov 14, 2019	SELL	$1.59 - $2.51 $16,163 - $25,516	-10,166 Reduced 62.86%	6,007 $11,000
Q2 2019 Aug 14, 2019	SELL	$2.49 - $5.45 $429,642 - $940,381	-172,547 Reduced 91.43%	16,173 $40,000
Q1 2019 May 15, 2019	BUY	$1.47 - $5.91 $277,413 - $1.12 Million	188,717 Added 6290566.5%	188,720 $744,000
Q3 2018 Nov 14, 2018	SELL	$2.2 - $3.45 $3,326 - $5,216	-1,512 Reduced 99.8%	3 $0
Q2 2018 Apr 21, 2020	SELL	$2.0 - $3.3 $6 - $9	-3 Reduced 0.2%	1,515 $4,000
Q2 2018 Aug 14, 2018	SELL	$2.0 - $3.3 $7,072 - $11,668	-3,536 Reduced 69.96%	1,518 $3,000
Q1 2018 Oct 18, 2019	BUY	$1.25 - $4.6 $1,127 - $4,149	902 Added 21.72%	5,054 $10,000
Q1 2018 May 15, 2018	SELL	$1.25 - $4.6 $5,392 - $19,844	-4,314 Reduced 50.96%	4,152 $8,000
Q4 2017 Feb 14, 2018	BUY	$3.9 - $7.4 $18,435 - $34,979	4,727 Added 126.42%	8,466 $39,000
Q3 2017 Nov 14, 2017	BUY	$4.55 - $7.55 $17,012 - $28,229	3,739	3,739 $28,000

Others Institutions Holding OCX

# of Institutions

Shares Held

411K

Call Options Held

Put Options Held

View Full List

About Oncocyte Corp

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $266M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

More about OCX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account